Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov

Table 10_3_4.1
Hospital patients with an anticoagulant-related adverse drug event with IV heparin, United States, 2004 and 2006a
Population group 2006 2004
Exposed Adverse events Percent SE Exposed Adverse events Percent SE
Total 1,470 228 15.5 0.9 2,244 327 14.6 0.7
Age Under 65 220 38 17.3 2.6 353 35 9.9 1.6
65–74 517 73 14.1 1.5 855 117 13.7 1.2
75–84 515 87 16.9 1.7 798 134 16.8 1.3
85 and over 218 30 13.8 2.3 238 41 17.2 2.4
Gender Male 765 116 15.2 1.3 1,191 171 14.4 1.0
Female 705 112 15.9 1.4 1,053 156 14.8 1.1
Race White 1,253 187 14.9 1.0 1,904 281 14.8 0.8
Black 148 30 20.3 3.3 230 34 14.8 2.3
Other 69 11 15.9 4.4 110 12 10.9 3.0
Diabetes Yes 572 98 17.1 1.6 819 118 14.4 1.2
No 898 130 14.5 1.2 1,425 209 14.7 0.9
Obesity Yes 260 39 15.0 2.2 307 39 12.7 1.9
No 1,210 189 15.6 1.0 1,937 288 14.9 0.8
Cerebrovascular disease Yes 419 78 18.6 1.9 669 102 15.2 1.4
No 1,051 150 14.3 1.1 1,575 225 14.3 0.9
CHF/pulmonary edema Yes 609 116 19.1 1.6 837 151 18.0 1.3
No 861 112 13.0 1.2 1,407 176 12.5 0.9
COPD Yes 476 93 19.5 1.8 660 111 16.8 1.5
No 994 135 13.6 1.1 1,584 216 13.6 0.9
Smoking Yes 247 37 15.0 2.3 411 64 15.6 1.8
No 1,223 191 15.6 1.0 1,833 263 14.3 0.8
Cancer Yes DNA DNA DNA DNA 463 79 17.1 1.7
No DNA DNA DNA DNA 1,781 248 13.9 0.8
Corticosteroids Yes 106 19 17.9 3.7 162 33 20.4 3.2
No 1,364 209 15.3 1.0 2,082 294 14.1 0.8
Coronary artery disease Yes 951 149 15.7 1.2 1,594 251 15.7 0.9
No 519 79 15.2 1.6 650 76 11.7 1.3
Renal disease Yes 564 123 21.8 1.7 702 122 17.4 1.4
No 906 105 11.6 1.1 1,542 205 13.3 0.9

a Data include Medicare beneficiaries discharged from January to December.

DNA - Data have not been analyzed.

Key: CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; SE: standard error.

Source: Centers for Medicare & Medicaid Services, Medicare Patient Safety Monitoring System.

 

AHRQ Advancing Excellence in Health Care